Анализ нормативных, регуляторных аспектов доступности и бесплатного лекарственного обеспечения противосудорожных препаратов
DOI:
https://doi.org/10.53498/0wg5q932Ключевые слова:
эпилепсия, лекарственное обеспечение, противоэпилептические препараты, нормативно-правовое регулирование, здравоохранение в КазахстанеАннотация
Проблема доступности противоэпилептических препаратов остаётся одной из наиболее актуальных в системе здравоохранения. Несмотря на наличие в Казахстане гарантированного объема бесплатной медицинской помощи и системы обязательного социального медицинского страхования, обеспечение противоэпилептических препаратов часто сопровождается нормативными, организационными и логистическими трудностями. Это отражается на качестве и непрерывности лечения, что делает изучение регуляторных аспектов особенно важным. Цель исследования: анализ мирового и национального опыта обеспечения противоэпилептических препаратов (ПЭП), выявление основных барьеров доступности ПЭП в Казахстане и определение направлений совершенствования нормативно-правовой базы. Поиск и анализ материалов проводился за последние 5 лет, на основе нормативно-правовых ресурсов Adilet.kz, международных научных баз PubMed и Google Scholar, а также отчётов и исследовательских материалов, публикаций Всемирной организации здравоохранения и работ, посвящённых мировым принципам обеспечения доступности противоэпилептических препаратов. Полученные данные позволили выявить ключевые барьеры в обеспечении противоэпилептических препаратов и определить направления для совершенствования нормативно-правовой базы, что способствует повышению доступности лечения.
Библиографические ссылки
1. Vera-González, A. (2022). Pathophysiological mechanisms underlying the etiologies of seizures and epilepsy. In S. J. Czuczwar (Ed.), Epilepsy (Chapter). Exon Publications. https://doi.org/10.36255/exon-publications-epilepsy-pathopysiology
2. Löscher, W., Potschka, H., Sisodiya, S. M., Vezzani, A. (2020). Drug resistance in epilepsy: Clinical impact, potential mechanisms, and new innovative treatment options. Pharmacological Reviews, 72(3), 606–638. https://doi.org/10.1124/pr.120.019539
3. World Health Organization. (2019). Epilepsiia: Vazhneishaia zadacha obshchestvennogo zdravookhraneniia. Reziume (WHO/MSD/MER/19.2). Vsemirnaia organizatsiia zdravookhraneniia (Epilepsy: A major public health challenge. Summary (WHO/MSD/MER/19.2)) [in Russian]. Electronic resource. Access mode: https://www.ilae.org/
4. Pellinen, J. (2022). Treatment gaps in epilepsy. Frontiers in Epidemiology, 2, 976039. https://doi.org/10.3389/fepid.2022.976039
5. Kazakstan Respublikasy Prezidentіnіn Zharlygy. Kazakstan Respublikasynyn densaulyk saktau salasyn damytudyn 2011 - 2015 zhyldarga arnalgan "Salamatty Kazakstan" memlekettіk bagdarlamasyn bekіtu turaly (On approval of the State Program for the Development of the Healthcare Sector of the Republic of Kazakhstan "Salamatty Kazakhstan" for 2011-2015), 2010 zhylgy 29 karasha, N 1113 [in Kazakh]. https://adilet.zan.kz/kaz/docs/U1000001113
6. Kazakstan Respublikasy Ukіmetіnіn kaulysy. (2010). Kazakstan Respublikasynyn densaulyk saktau salasyn damytudyn 2016-2019 zhyldarga arnalgan "Densaulyk" memlekettіk bagdarlamasyn bekіtu turaly (About the approval of the State program for the development of health care of the Republic of Kazakhstan "Health" for 2016-2019), 2018 zhylgy 15 kazan, № 634 қaulysy [in Kazakh]. https://adilet.zan.kz/kaz/docs/P1800000634
7. Ministerstvo zdravookhraneniia RK. (2019). Gosudarstvennaia programma razvitiia zdravookhraneniia Respubliki Kazakhstan na 2020–2025 gody (State Program for the Development of Healthcare in the Republic of Kazakhstan for 2020–2025) [in Russian]. Electronic resource. Access mode: https://primeminister.kz/assets/media/gosudarstvennaya-programma-razvitiya-zdravookhraneniya-respubliki-kazakhstan-na-2020-2025-gody.pdf
8. Gulis, G., Aringazina, A., Sangilbayeva, Z., Kalel, Z., de Leeuw, E., & Allegrante, J. P. (2021). Population health status of the Republic of Kazakhstan: Trends and implications for public health policy. International Journal of Environmental Research and Public Health, 18(22), 12235. https://doi.org/10.3390/ijerph182212235
9. Kazakstan Respublikasy Densaulyk saktau ministrі. (2020). Aleumettіk manі bar aurulardyn tіzbesіn bekіtu turaly (On approval of the list of diseases of social significance). [in Kazakh]. https://adilet.zan.kz/kaz/docs/V2000021263
10. Kazakstan Respublikasy Densaulyk saқtau ministrі. (2023). Tegіn meditsinalyқ komektіn kepіldіk berіlgen kolemі shenberіnde, tergeu izoliatorlary men kylmystyk-atkaru (penitentsiarlyk) zhuiesіnіn mekemelerіnde ustalatyn adamdar ushіn meditsinalyk komektіn kosymsha kolemіn biudzhet karazhaty esebіnen zhane (nemese) mіndettі aleumettіk meditsinalyn saktandyru zhuiesіnde darіlіk zattardy, meditsinalyk buiymdardy zhane arnaiy emdіk onіmderdі satyp aludy, farmatsevtikalyk korsetіletіn kyzmetterdі satyp aludy uiymdastyru zhane otkіzu kagidalaryn bekіtu turaly (On approval of the Rules for organizing and conducting the procurement of medicines, medical devices, and specialized therapeutic products, as well as pharmaceutical services, for persons held in pre-trial detention centers and institutions of the criminal-executive (penitentiary) system, within the guaranteed volume of free medical care, financed from budgetary funds and/or within the system of compulsory social health insurance). https://adilet.zan.kz/kaz/docs/V2300032733
11. Pironi, V., Ciccone, O., Beghi, E., Paragua-Zuellig, H., Patel, A. A., Giussani, G., Bianchi, E., Venegas, V., & Vigevano, F. (on behalf of the ILAE Task Force on Access to Treatment). (2022). Survey on the worldwide availability and affordability of antiseizure medications: Report of the ILAE Task Force on Access to Treatment. Epilepsia, 63(2), 335–351. https://doi.org/10.1111/epi.17155
12. Kazakstan Respublikasy Ukіmetі (2020). Kazakstan Respublikasynyn densaulyk saktau salasyn damytudyn 2020- 2025 zhyldarga arnalgan memlekettіk bagdarlamasyn bekіtu turaly (On approval of the State Program for the Development of the Healthcare Sector of the Republic of Kazakhstan for 2020-2025) [in Kazakh]. https://adilet.zan.kz/kaz/docs/P1900000982
13. Kazakstan Respublikasy Densaulyk saktau ministrі. (2023). Tegіn meditsinalyk komektіn kepіldіk berіlgen kolemі shenberіnde, tergeu izoliatorlary men kylmystyk-atkaru (penitentsiarlyk) zhuiesіnіn mekemelerіnde ustalatyn adamdar ushіn meditsinalyk komektіn kosymsha kolemіn biudzhet karazhaty esebіnen zhane (nemese) mіndettі aleumettіk meditsinalyk saktandyru zhuiesіnde darіlіk zattardy, meditsinalyn buiymdardy zhane arnaiy emdіk onіmderdі satyp aludy, farmatsevtikalyk korsetіletіn kyzmetterdі satyp aludy uiymdastyru zhane otkіzu kagidalaryn bekіtu turaly (On approval of the Rules for organizing and conducting the procurement of medicines, medical devices, and specialized therapeutic products, as well as pharmaceutical services, for persons held in pre-trial detention centers and institutions of the criminal-executive (penitentiary) system, within the guaranteed volume of free medical care, financed from budgetary funds and/or within the system of compulsory social health insurance). [in Kazakh]. https://adilet.zan.kz/kaz/docs/V2300032733
14. Chan, A. Y. L., Yuen, A. S. C., Hsia, Y., Lau, W. C. Y., Cross, J. H., Walker, M. C., Besag, F. M. C., Hung, A. T. F., Iessa, N., Chowdhary, N., Man, K. K. C., & Wong, I. C. K. (2025). Antiseizure medications consumption in 73 countries and regions from 2012 to 2022: A longitudinal trend study. eClinicalMedicine, 89, 103558. https://doi.org/10.1016/j.eclinm.2025.103558
15. World Health Organization, International League Against Epilepsy, & International Bureau for Epilepsy. (2019). Global report: Epilepsy – a public health imperative. https://www.who.int/publications/i/item/WHO-MSD-MER-19.22019
16. Akhmedullin, R., Kozhobekova, B., Gusmanov, A., Aimyshev, T., Utebekov, Z., Kyrgyzbay, G., Shpekov, A., & Gaipov, A. (2024). Epilepsy trends in Kazakhstan: A retrospective longitudinal study using data from unified national electronic health system 2014–2020. Seizure, 122, 58–63. https://doi.org/10.1016/j.seizure.2024.09.022
17. Korzh, I., Olieinikova, N., Beketova, M., Kubarieva, I., Korobova, Y., Sevriukov, O., & Afanasenko, O. (2022). Comparative analysis of drug consumption for the treatment of epilepsy in Ukraine, Kazakhstan and Belarus. ScienceRise: Pharmaceutical Science, 2(36), 26–36. https://doi.org/10.15587/2519-4852.2022.255840
18. Jacob, L., Kerimbaeva, Z., Kalyapin, A., & Kostev, K. (2019). Prescription patterns of antiepileptic drugs in Kazakhstan in 2018: A retrospective study of 57,959 patients. Epilepsy & Behavior, 99, 106445. https://doi.org/10.1016/j.yebeh.2019.106445
19. Guekht, A., Zharkinbekova, N., Shpak, A., & Hauser, W. A. (2017). Epilepsy and treatment gap in urban and rural areas of the Southern Kazakhstan in adults. Epilepsy & Behavior, 67, 98–104. https://doi.org/10.1016/j.yebeh.2016.11.028
20. Kazakstan Respublikasy Densaulyk saktau ministrі. (2010). Densaulyk saktau salasyndagy keibіr buiryқtardyn kushі zhoiyldy dep tanu turaly (On the recognition of some orders in the field of health care as invalid) [in Kazakh]. https://adilet.zan.kz/kaz/docs/A10R0001922
21. Alieva, N. A., Esimova, A. K., Bekzhanova, A. M. (2020). The pharmaceutical market of Kazakhstan in the context of global trends. Bulletin of L. N. Gumilyov Eurasian National University. Series: Economics, 3(132), 119–128. https://doi.org/10.32523/2079‑620X‑2020‑4‑21‑35
22. Zhakipbekov, K., Sadikov, B., Myrzabekova, G., & Kydyrbaeva, Z. (2023). Pharmaceutical market analysis and development trends in Kazakhstan. ScienceRise: Pharmaceutical Science, 2(42), 45–52. https://doi.org/10.15587/2519-4852.2023.267787
23. Kazakstan Respublikasy Densaulyk saktau ministrі. (2020). Zharamsyz bolyp kalgan, zharamdylyk merzіmі otken darіlіk zattar men meditsinalyқ buiymdardy, zhalgan zhane Kazakstan Respublikasy zaңnamasynyn talaptaryna saikes kelmeitіn basқa da darіlіk zattar men meditsinalyk buiymdardy zhoiu kagidalaryn bekіtu turaly (Zharamsyz bolyp kalgan, zharamdylyk merzіmі otken dәrіlіk zattar men medicinalyk buyimdardy, zhalgan zhane Kazakhstan Republics zanamasynyn talaptaryna sәikes kelmeytin baska yes darilik zattar men medical science) [in Kazakh]. https://adilet.zan.kz/kaz/docs/V2000021533
24. Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., Nordli, D. R., Perucca, E., Tomson, T., Wiebe, S., Zhang, Y. H., Zuberi, S. M. (2017). ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 58(4), 512–521. https://doi.org/10.1111/epi.13709
25. Begley, C. E., Durgin, T. L. (2015). The direct cost of epilepsy in the United States: A systematic review of estimates. Epilepsia, 56(9), 1376–1387. https://doi.org/10.1111/epi.13084
26. Gusmanov, A., Zhakhina, G., Yerdessov, S., Sakko, Y., Mussina, K., Alimbayev, A., Syssoyev, D., Sarria-Santamera, A., Gaipov, A. (2023). Review of the research databases on population-based registries of unified electronic healthcare system of Kazakhstan (UNEHS): Possibilities and limitations for epidemiological research and real-world evidence. International Journal of Medical Informatics, 170, 104950. https://doi.org/10.1016/j.ijmedinf.2022.104950
